Meeder Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Meeder Asset Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-611	Closed	-$13K	–	2628
2019 Q4	$13K	Buy	+611	New	+$10.3K	﹤0.01%	1497
2019 Q3	–	Sell	-236	Closed	-$3K	–	2321
2019 Q2	$3K	Buy	+236	New	+$2.72K	﹤0.01%	1826
2017 Q3	–	Sell	-194	Closed	-$4K	–	1812
2017 Q2	$4K	Sell	194 -122	-39%	-$2.54K	﹤0.01%	1289
2017 Q1	$9K	Hold	316	–	–	﹤0.01%	892
2016 Q4	$6K	Buy	+316	New	+$6.04K	﹤0.01%	843

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Meeder Asset Management's FLXN Position: Q1 2020 in Review

Meeder Asset Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 611 shares — an estimated $13K sold.

Meeder Asset Management first reported a position in FLXN in Q4 2016 and held it in 5 quarters. The position peaked at $13K in Q4 2019. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

Meeder Asset Management reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Meeder Asset Management sold 611 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $13K.
Meeder Asset Management first reported a position in Flexion Therapeutics, Inc. in Q4 2016 and held it in 5 quarters.
Meeder Asset Management's Flexion Therapeutics, Inc. position peaked at $13K in Q4 2019.
123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Meeder Asset Management's 13F filing for Q1 2020, filed 15 May 2020.